Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 5,160 shares at $96.06 ($502K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $502k NUVL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.06 | 513 | $49K | 9.8% |
| 2 | $96.85 | 660 | $64K | 12.7% |
| 3 | $97.96 | 1,137 | $111K | 22.2% |
| 4 | $98.52 | 186 | $18K | 3.7% |
| 5 | $96.75 | 1,106 | $107K | 21.3% |
| 6 | $97.33 | 1,369 |
| $133K |
| 26.6% |
| 7 | $98.40 | 189 | $19K | 3.7% |
| Total | $97.24 avg | 5,160 | $502K | 100% |
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |
| NUVL | SELL | 2025-10-15 | $1.8M | — | Filing → |